+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Fibroblast Growth Factors Market - Global Forecast 2025-2030- Product Image
Fibroblast Growth Factors Market - Global Forecast 2025-2030- Product Image
Sale

Fibroblast Growth Factors Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 191 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6117273
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Fibroblast growth factors (FGFs) are integral to the evolving landscape of advanced therapies and diagnostics, presenting decision-makers with opportunities to address unmet clinical and research challenges. This report offers actionable intelligence on FGF trends, regulatory shifts, and emerging opportunities, enabling senior leaders to position their organizations at the forefront of this dynamic market.

Market Snapshot: Fibroblast Growth Factor Market Overview

The fibroblast growth factor market is undergoing rapid transformation, driven by advances in molecular biology, protein engineering, and delivery technology. Market participants include a blend of established industry leaders, emerging biotech firms, and academic research centers. Diverse applications—spanning diagnostics, research, and therapeutics—are shaping competitive dynamics. Accelerated clinical translation and regulatory adaptation are positioning FGFs as core agents in regenerative medicine, oncology, metabolic disorders, and tissue repair. Industry consolidation, cross-sector partnerships, and targeted investment are helping organizations mitigate supply risks and capitalize on product innovation.

Scope & Segmentation

This report systematically categorizes the fibroblast growth factor market, offering clarity on its multi-faceted structure and critical sub-segments:

  • Type: FGF1, FGF2, FGF21, FGF7
  • Application: Diagnostics, Research, Therapeutics (Cardiovascular, Metabolic Disorders, Oncology, Wound Healing — Injectable, Topical)
  • End User: Diagnostic Labs, Hospitals, Pharmaceutical and Biotech Companies (Large Pharma, Small Pharma), Research Institutes
  • Therapeutic Area: Cardiovascular, Metabolic Disorders, Oncology, Wound Healing (Injectable, Topical)
  • Form: Recombinant Protein, Synthetic Peptide
  • Regions: Americas (including US states: California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio; Canada; Mexico; Brazil; Argentina), Europe, Middle East & Africa (including UK, Germany, France, Russia, Italy, Spain, UAE, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Technologies: High-resolution crystallography, high-throughput screening, nanoparticle and hydrogel delivery, gene editing (CRISPR), bioactive scaffolds, advanced bioprocess optimization
  • Key Companies: Thermo Fisher Scientific Inc., Merck KGaA, Bio-Techne Corporation, Cytiva US LLC, Abcam PLC, STEMCELL Technologies Inc., Miltenyi Biotec GmbH, PromoCell GmbH, Becton, Dickinson and Company, Lonza Group Ltd.

Key Takeaways: Strategic Insights for Senior Decision-Makers

  • Transformational advances in FGF ligand-receptor structural elucidation are improving molecular specificity and driving compound screening efforts for targeted therapeutic modulation.
  • Breakthroughs in delivery technologies—such as lipid nanoparticles and hydrogels—are boosting administration precision, enhancing efficacy, and reducing off-target effects in clinical applications.
  • Regulatory bodies are introducing streamlined pathways for engineered FGF entities, reflecting increased confidence in their safety profiles and encouraging innovative product development.
  • Collaborations between academia, biotech start-ups, and large pharmaceutical companies are accelerating clinical development, while multi-region manufacturing strategies support global supply chain continuity.
  • Application-focused growth is most pronounced in metabolic disease, oncology, and tissue repair, with individualized therapeutic approaches enabled by gene editing and personalized delivery systems.
  • End users, including research laboratories, hospitals, and vertically integrated pharma companies, prioritize high-quality recombinant proteins and robust assay platforms to ensure consistent research and clinical outcomes.

United States Tariff Impact: Navigating 2025 Policy Developments

Recent US tariffs on recombinant proteins and synthetic peptides have increased operational costs for organizations with transnational supply chains. Institutions are adapting with localized procurement, strategic partnerships, and investment in domestic bioprocessing capabilities. While short-term disruption is expected, long-term shifts emphasize bioprocess innovation and regional manufacturing as key mitigation strategies. FGF product developers must monitor policy adjustments to maintain progress toward therapeutic and research milestones.

Methodology & Data Sources

This analysis integrates primary interviews with industry leaders, academic experts, and clinical investigators alongside secondary sources in peer-reviewed journals, clinical trial registries, and regulatory filings. Quantitative insights rely on publication databases, patent records, and public financial disclosures. Analytical frameworks—including SWOT, Porter’s Five Forces, and PESTEL—support the findings. An expert panel reviewed all insights, ensuring robust validation.

Why This Report Matters

  • Enables senior decision-makers to benchmark market position, align product strategies with regulatory and technological trends, and anticipate disruptive changes in the fibroblast growth factor market.
  • Supports informed investment and R&D prioritization by mapping segment relevance, regional dynamics, and supply chain developments.
  • Offers actionable strategic recommendations to capitalize on emerging opportunities and safeguard against regulatory and operational risks.

Conclusion

The fibroblast growth factor market offers an array of opportunities across research and therapy, driven by scientific advances and evolving regulations. Strategic alignment and proactive adaptation are essential to unlocking the full value of FGFs within the current competitive landscape.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Emergence of long-acting FGF-based therapies targeting type 2 diabetes and obesity management with enhanced safety profiles
5.2. Growing investment in FGF-loaded hydrogel scaffolds for accelerated bone and cartilage tissue regeneration applications
5.3. Approval and commercialization of FGF analogs in dermatology for advanced skin repair and antiaging treatment portfolios
5.4. Strategic collaborations between biotech companies and academia to develop novel FGF inhibitors for oncology indications
5.5. Integration of targeted FGF signaling modulators into precision medicine pipelines for personalized cancer therapy approaches
5.6. Rise of nanoparticle delivery systems for controlled release of FGF growth factors in cardiovascular tissue engineering
5.7. Expansion of FGF21 biosimilar manufacturing capacity to address global demand for metabolic syndrome therapeutics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Fibroblast Growth Factors Market, by Type
8.1. Introduction
8.2. Fgf1
8.3. Fgf2
8.4. Fgf21
8.5. Fgf7
9. Fibroblast Growth Factors Market, by Application
9.1. Introduction
9.2. Diagnostics
9.3. Research
9.4. Therapeutics
9.4.1. Cardiovascular
9.4.2. Metabolic Disorders
9.4.3. Oncology
9.4.4. Wound Healing
9.4.4.1. Injectable
9.4.4.2. Topical
10. Fibroblast Growth Factors Market, by End User
10.1. Introduction
10.2. Diagnostic Labs
10.3. Hospitals
10.4. Pharmaceutical And Biotech Companies
10.4.1. Large Pharma
10.4.2. Small Pharma
10.5. Research Institutes
11. Fibroblast Growth Factors Market, by Therapeutic Area
11.1. Introduction
11.2. Cardiovascular
11.3. Metabolic Disorders
11.4. Oncology
11.5. Wound Healing
11.5.1. Injectable
11.5.2. Topical
12. Fibroblast Growth Factors Market, by Form
12.1. Introduction
12.2. Recombinant Protein
12.3. Synthetic Peptide
13. Americas Fibroblast Growth Factors Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Fibroblast Growth Factors Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Fibroblast Growth Factors Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Thermo Fisher Scientific Inc.
16.3.2. Merck KGaA
16.3.3. Bio-Techne Corporation
16.3.4. Cytiva US LLC
16.3.5. Abcam PLC
16.3.6. STEMCELL Technologies Inc.
16.3.7. Miltenyi Biotec GmbH
16.3.8. PromoCell GmbH
16.3.9. Becton, Dickinson and Company
16.3.10. Lonza Group Ltd.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. FIBROBLAST GROWTH FACTORS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2030 (%)
FIGURE 12. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY FORM, 2024 VS 2030 (%)
FIGURE 14. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS FIBROBLAST GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS FIBROBLAST GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES FIBROBLAST GROWTH FACTORS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES FIBROBLAST GROWTH FACTORS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA FIBROBLAST GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA FIBROBLAST GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC FIBROBLAST GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC FIBROBLAST GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. FIBROBLAST GROWTH FACTORS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. FIBROBLAST GROWTH FACTORS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. FIBROBLAST GROWTH FACTORS MARKET: RESEARCHAI
FIGURE 26. FIBROBLAST GROWTH FACTORS MARKET: RESEARCHSTATISTICS
FIGURE 27. FIBROBLAST GROWTH FACTORS MARKET: RESEARCHCONTACTS
FIGURE 28. FIBROBLAST GROWTH FACTORS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. FIBROBLAST GROWTH FACTORS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY FGF1, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY FGF1, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY FGF2, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY FGF2, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY FGF21, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY FGF21, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY FGF7, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY FGF7, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY THERAPEUTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY WOUND HEALING, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY WOUND HEALING, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY INJECTABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY TOPICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY DIAGNOSTIC LABS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY DIAGNOSTIC LABS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY LARGE PHARMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY LARGE PHARMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY SMALL PHARMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY SMALL PHARMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH COMPANIES, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH COMPANIES, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY WOUND HEALING, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY WOUND HEALING, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY INJECTABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY TOPICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY RECOMBINANT PROTEIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY RECOMBINANT PROTEIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY SYNTHETIC PEPTIDE, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY SYNTHETIC PEPTIDE, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS FIBROBLAST GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS FIBROBLAST GROWTH FACTORS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS FIBROBLAST GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS FIBROBLAST GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS FIBROBLAST GROWTH FACTORS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS FIBROBLAST GROWTH FACTORS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS FIBROBLAST GROWTH FACTORS MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS FIBROBLAST GROWTH FACTORS MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS FIBROBLAST GROWTH FACTORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS FIBROBLAST GROWTH FACTORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS FIBROBLAST GROWTH FACTORS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH COMPANIES, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS FIBROBLAST GROWTH FACTORS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH COMPANIES, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS FIBROBLAST GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS FIBROBLAST GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS FIBROBLAST GROWTH FACTORS MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS FIBROBLAST GROWTH FACTORS MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS FIBROBLAST GROWTH FACTORS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS FIBROBLAST GROWTH FACTORS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS FIBROBLAST GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS FIBROBLAST GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES FIBROBLAST GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES FIBROBLAST GROWTH FACTORS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES FIBROBLAST GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES FIBROBLAST GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES FIBROBLAST GROWTH FACTORS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES FIBROBLAST GROWTH FACTORS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES FIBROBLAST GROWTH FACTORS MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES FIBROBLAST GROWTH FACTORS MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES FIBROBLAST GROWTH FACTORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES FIBROBLAST GROWTH FACTORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES FIBROBLAST GROWTH FACTORS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH COMPANIES, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES FIBROBLAST GROWTH FACTORS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH COMPANIES, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES FIBROBLAST GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES FIBROBLAST GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES FIBROBLAST GROWTH FACTORS MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES FIBROBLAST GROWTH FACTORS MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES FIBROBLAST GROWTH FACTORS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES FIBROBLAST GROWTH FACTORS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES FIBROBLAST GROWTH FACTORS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES FIBROBLAST GROWTH FACTORS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 121. CANADA FIBROBLAST GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 122. CANADA FIBROBLAST GROWTH FACTORS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 123. CANADA FIBROBLAST GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 124. CANADA FIBROBLAST GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 125. CANADA FIBROBLAST GROWTH FACTORS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 126. CANADA FIBROBLAST GROWTH FACTORS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 127. CANADA FIBROBLAST GROWTH FACTORS MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
TABLE 128. CANADA FIBROBLAST GROWTH FACTORS MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
TABLE 129. CANADA FIBROBLAST GROWTH FACTORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 130. CANADA FIBROBLAST GROWTH FACTORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 131. CANADA FIBROBLAST GROWTH FACTORS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH COMPANIES, 2018-2024 (USD MILLION)
TABLE 132. CANADA FIBROBLAST GROWTH FACTORS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH COMPANIES, 2025-2030 (USD MILLION)
TABLE 133. CANADA FIBROBLAST GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 134. CANADA FIBROBLAST GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 135. CANADA FIBROBLAST GROWTH FACTORS MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
TABLE 136. CANADA FIBROBLAST GROWTH FACTORS MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
TABLE 137. CANADA FIBROBLAST GROWTH FACTORS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 138. CANADA FIBROBLAST GROWTH FACTORS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 139. MEXICO FIBROBLAST GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 140. MEXICO FIBROBLAST GROWTH FACTORS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 141. MEXICO FIBROBLAST GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 142. MEXICO FIBROBLAST GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 143. MEXICO FIBROBLAST GROWTH FACTORS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 144. MEXICO FIBROBLAST GROWTH FACTORS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 145. MEXICO FIBROBLAST GROWTH FACTORS MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
TABLE 146. MEXICO FIBROBLAST GROWTH FACTORS MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
TABLE 147. MEXICO FIBROBLAST GROWTH FACTORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 148. MEXICO FIBROBLAST GROWTH FACTORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 149. MEXICO FIBROBLAST GROWTH FACTORS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH COMPANIES, 2018-2024 (USD MILLION)
TABLE 150. MEXICO FIBROBLAST GROWTH FACTORS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH COMPANIES, 2025-2030 (USD MILLION)
TABLE 151. MEXICO FIBROBLAST GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 152. MEXICO FIBROBLAST GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 153. MEXICO FIBROBLAST GROWTH FACTORS MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
TABLE 154. MEXICO FIBROBLAST GROWTH FACTORS MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
TABLE 155. MEXICO FIBROBLAST GROWTH FACTORS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 156. MEXICO FIBROBLAST GROWTH FACTORS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 157. BRAZIL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 158. BRAZIL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 159. BRAZIL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 160. BRAZIL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 161. BRAZIL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 162. BRAZIL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 163. BRAZIL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
TABLE 164. BRAZIL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
TABLE 165. BRAZIL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 166. BRAZIL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 167. BRAZIL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH COMPANIES, 2018-2024 (USD MILLION)
TABLE 168. BRAZIL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH COMPANIES, 2025-2030 (USD MILLION)
TABLE 169. BRAZIL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 170. BRAZIL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 171. BRAZIL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
TABLE 172. BRAZIL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL FIBROBLAST GROWTH FACTORS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 175. ARGENTINA FIBROBLAST GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 176. ARGENTINA FIBROBLAST GROWTH FACTORS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 177. ARGENTINA FIBROBLAST GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 178. ARGENTINA FIBROBLAST GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 179. ARGENTINA FIBROBLAST GROWTH FACTORS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 180. ARGENTINA FIBROBLAST GROWTH FACTORS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 181. ARGENTINA FIBROBLAST GROWTH FACTORS MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
TABLE 182. ARGENTINA FIBROBLAST GROWTH FACTORS MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
TABLE 183. ARGENTINA FIBROBLAST GROWTH FACTORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 184. ARGENTINA FIBROBLAST GROWTH FACTORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 185. ARGENTINA FIBROBLAST GROWTH FACTORS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH COMPANIES, 2018-2024 (USD MILLION)
TABLE 186. ARGENTINA FIBROBLAST GROWTH FACTORS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH COMPANIES, 2025-2030 (USD MILLION)
TABLE 187. ARGENTINA FIBROBLAST GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 188. ARGENTINA FIBROBLAST GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 189. ARGENTINA FIBROBLAST GROWTH FACTORS MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
TABLE 190. ARGENTINA FIBROBLAST GROWTH FACTORS MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
TABLE 191. ARGENTINA FIBROBLAST GROWTH FACTORS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 192. ARGENTINA FIBROBLAST GROWTH FACTORS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA FIBROBLAST GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA FIBROBLAST GROWTH FACTORS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA FIBROBLAST GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA FIBROBLAST GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA FIBROBLAST GROWTH FACTORS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA FIBROBLAST GROWTH FACTORS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA FIBROBLAST GROWTH FACTORS MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA FIBROBLAST GROWTH FACTORS MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA FIBROBLAST GROWTH FACTORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA FIBROBLAST GROWTH FACTORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA FIBROBLAST GROWTH FACTORS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH COMPANIES, 2018-2024 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA FIBROBLAST GROWTH FACTORS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH COMPANIES, 2025-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA FIBROBLAST GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA FIBROBLAST GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA FIBROBLAST GROWTH FACTORS MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA FIBROBLAST GROWTH FACTORS MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA FIBROBLAST GROWTH FACTORS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA FIBROBLAST GROWTH FACTORS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA FIBROBLAST GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA FIBROBLAST GROWTH FACTORS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 213. UNITED KINGDOM FIBROBLAST GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 214. UNITED KINGDOM FIBROBLAST GROWTH FACTORS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 215. UNITED KINGDOM FIBROBLAST GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 216. UNITED KINGDOM FIBROBLAST GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 217. UNITED KINGDOM FIBROBLAST GROWTH FACTORS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 218. UNITED KINGDOM FIBROBLAST GROWTH FACTORS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 219. UNITED KINGDOM FIBROBLAST GROWTH FACTORS MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
TABLE 220. UNITED KINGDOM FIBROBLAST GROWTH FACTORS MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
TABLE 221. UNITED KINGDOM FIBROBLAST GROWTH FACTORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 222. UNITED KINGDOM FIBROBLAST GROWTH FACTORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 223. UNITED KINGDOM FIBROBLAST GROWTH FACTORS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH COMPANIES, 2018-2024 (USD MILLION)
TABLE 224. UNITED KINGDOM FIBROBLAST GROWTH FACTORS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH COMPANIES, 2025-2030 (USD MILLION)
TABLE 225. UNITED KINGDOM FIBROBLAST GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 226. UNITED KINGDOM FIBROBLAST GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 227. UNITED KINGDOM FIBROBLAST GROWTH FACTORS MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
TABLE 228. UNITED KINGDOM FIBROBLAST GROWTH FACTORS MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM FIBROBLAST GROWTH FACTORS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 230. UNITED KINGDOM FIBROBLAST GROWTH FACTORS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 231. GERMANY FIBROBLAST GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 232. GERMANY FIBROBLAST GROWTH FACTORS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 233. GERMANY FIBROBLAST GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 234. GERMANY FIBROBLAST GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 235. GERMANY FIBROBLAST GROWTH FACTORS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 236. GERMANY FIBROBLAST GROWTH FACTORS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 237. GERMANY FIBROBLAST GROWTH FACTORS MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
TABLE 238. GERMANY FIBROBLAST GROWTH FACTORS MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
TABLE 239. GERMANY FIBROBLAST GROWTH FACTORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 240. GERMANY FIBROBLAST GROWTH FACTORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 241. GERMANY FIBROBLAST GROWTH FACTORS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH COMPANIES, 2018-2024 (USD MILLION)
TABLE 242. GERMANY FIBROBLAST GROWTH FACTORS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH COMPANIES, 2025-2030 (USD MILLION)
TABLE 243. GERMANY FIBROBLAST GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 244. GERMANY FIBROBLAST GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 245. GERMANY FIBROBLAST GROWTH FACTORS MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
TABLE 246. GERMANY FIBROBLAST GROWTH FACTORS MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
TABLE 247. GERMANY FIBROBLAST GROWTH FACTORS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 248. GERMANY FIBROBLAST GROWTH FACTORS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 249. FRANCE FIBROBLAST GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 250. FRANCE FIBROBLAST GROWTH FACTORS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 251. FRANCE FIBROBLAST GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 252. FRANCE FIBROBLAST GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 253. FRANCE FIBROBLAST GROWTH FACTORS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 254. FRANCE FIBROBLAST GROWTH FACTORS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 255. FRANCE FIBROBLAST GROWTH FACTORS MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
TABLE 256. FRANCE FIBROBLAST GROWTH FACTORS MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
TABLE 257. FRANCE FIBROBLAST GROWTH FACTORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 258. FRANCE FIBROBLAST GROWTH FACTORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 259. FRANCE FIBROBLAST GROWTH FACTORS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH COMPANIES, 2018-2024 (USD MILLION)
TABLE 260. FRANCE FIBROBLAST GROWTH FACTORS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH COMPANIES, 2025-2030 (USD MILLION)
TABLE 261. FRANCE FIBROBLAST GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 262. FRANCE FIBROBLAST GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 263. FRANCE FIBROBLAST GROWTH FACTORS MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
TABLE 264. FRANCE FIBROBLAST GROWTH FACTORS MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
TABLE 265. FRANCE FIBROBLAST GROWTH FACTORS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 266. FRANCE FIBROBLAST GROWTH FACTORS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 267. RUSSIA FIBROBLAST GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 268. RUSSIA FIBROBLAST GROWTH FACTORS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 269. RUSSIA FIBROBLAST GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 270. RUSSIA FIBROBLAST GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 271. RUSSIA FIBROBLAST GROWTH FACTORS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 272. RUSSIA FIBROBLAST GROWTH FACTORS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 273. RUSSIA FIBROBLAST GROWTH FACTORS MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
TABLE 274. RUSSIA FIBROBLAST GROWTH FACTORS MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
TABLE 275. RUSSIA FIBROBLAST GROWTH FACTORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 276. RUSSIA FIBROBLAST GROWTH FACTORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 277. RUSSIA FIBROBLAST GROWTH FACTORS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH COMPANIES, 2018-2024 (USD MILLION)
TABLE 278. RUSSIA FIBROBLAST GROWTH FACTORS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH COMPANIES, 2025-2030 (USD MILLION)
TABLE 279. RUSSIA FIBROBLAST GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 280. RUSSIA FIBROBLAST GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 281. RUSSIA FIBROBLAST GROWTH FACTORS MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
TABLE 282. RUSSIA FIBROBLAST GROWTH FACTORS MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
TABLE 283. RUSSIA FIBROBLAST GROWTH FACTORS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 284. RUSSIA FIBROBLAST GROWTH FACTORS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 285. ITALY FIBROBLAST GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 286. ITALY FIBROBLAST GROWTH FACTORS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 287. ITALY FIBROBLAST GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 288. ITALY FIBROBLAST GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 289. ITALY FIBROBLAST GROWTH FACTORS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 290. ITALY FIBROBLAST GROWTH FACTORS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 291. ITALY FIBROBLAST GROWTH FACTORS MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
TABLE 292. ITALY FIBROBLAST GROWTH FACTORS MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
TABLE 293. ITALY FIBROBLAST GROWTH FACTORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 294. ITALY FIBROBLAST GROWTH FACTORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 295. ITALY FIBROBLAST GROWTH FACTORS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH COMPANIES, 2018-2024 (USD MILLION)
TABLE 296. ITALY FIBROBLAST GROWTH FACTORS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH COMPANIES, 2025-2030 (USD MILLION)
TABLE 297. ITALY FIBROBLAST GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 298. ITALY FIBROBLAST GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 299. ITALY FIBROBLAST GROWTH FACTORS MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
TABLE 300. ITALY FIBROBLAST GROWTH FACTORS MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
TABLE 301. ITALY FIBROBLAST GROWTH FACTORS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 302. ITALY FIBROBLAST GROWTH FACTORS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 303. SPAIN FIBROBLAST GROWTH FACTORS MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
TABLE 304. SPAIN FIBROBLAST GROWTH FACTORS MARKET SIZE, BY TYPE, 2025-2030 (USD MILLION)
TABLE 305. SPAIN FIBROBLAST GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 306. SPAIN FIBROBLAST GROWTH FACTORS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 307. SPAIN FIBROBLAST GROWTH FACTORS MARKET SIZE, BY THERAPEUTICS, 2018-2024 (USD MILLION)
TABLE 308. SPAIN FIBROBLAST GROWTH FACTORS MARKET SIZE, BY THERAPEUTICS, 2025-2030 (USD MILLION)
TABLE 309. SPAIN FIBROBLAST GROWTH FACTORS MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
TABLE 310. SPAIN FIBROBLAST GROWTH FACTORS MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
TABLE 311. SPAIN FIBROBLAST GROWTH FACTORS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 312. SPAIN FIBROBLAST GROWTH FACTORS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 313. SPAIN FIBROBLAST GROWTH FACTORS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH COMPANIES, 2018-2024 (USD MILLION)
TABLE 314. SPAIN FIBROBLAST GROWTH FACTORS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECH COMPANIES, 2025-2030 (USD MILLION)
TABLE 315. SPAIN FIBROBLAST GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 316. SPAIN FIBROBLAST GROWTH FACTORS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 317. SPAIN FIBROBLAST GROWTH FACTORS MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
TABLE 318. SPAIN FIBROBLAST GROWTH FACTORS MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
TABLE 319. SPAIN FIBROBLAST GROWTH FACTORS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 320. SPAIN FIBROBLAST GROWTH FACTORS MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 321. UNITED

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Fibroblast Growth Factors market report include:
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Bio-Techne Corporation
  • Cytiva US LLC
  • Abcam PLC
  • STEMCELL Technologies Inc.
  • Miltenyi Biotec GmbH
  • PromoCell GmbH
  • Becton, Dickinson and Company
  • Lonza Group Ltd.

Related Topics

Related Reports

Recombinant Human Fibroblast Growth Factor Market - Global Forecast 2025-2030 - Product Image

Recombinant Human Fibroblast Growth Factor Market - Global Forecast 2025-2030

  • Report
  • 197 Pages
  • Global
From
Recombinant Human Fibroblast Growth Factor Kit Market - Global Forecast 2025-2030 - Product Image

Recombinant Human Fibroblast Growth Factor Kit Market - Global Forecast 2025-2030

  • Report
  • 189 Pages
  • Global
From
Fibroblast Growth Factors - Global Strategic Business Report - Product Image

Fibroblast Growth Factors - Global Strategic Business Report

  • Report
  • 486 Pages
  • Global
From
Fibroblast Growth Factors (FGFs) Global Market Report 2025 - Product Image

Fibroblast Growth Factors (FGFs) Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Type 1 Fibroblast Growth Factor Receptor Antagonists - Pipeline Insight, 2025 - Product Image

Type 1 Fibroblast Growth Factor Receptor Antagonists - Pipeline Insight, 2025

  • Drug Pipelines
  • 60 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.